Jubilant Pharmova Limited JUBLPHARMA.NS Open Jubilant Pharmova Limited in new tab
Jubilant Pharmova Limited Analysis (JUBLPHARMA.NS)
Is Jubilant Pharmova Limited a good investment? Jubilant Pharmova Limited (JUBLPHARMA.NS) is currently trading at 839.30 INR. Market analysts have a consensus price target of 1312.50 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 30.77. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Jubilant Pharmova Limited is expected to release its next earnings report on May 14, 2026. The market consensus estimate for Forward EPS is 36.30.
For income investors, Jubilant Pharmova Limited pays a dividend yield of 0.60%. With a payout ratio of 18%, the dividend appears sustainable.
Investor FAQ
Does Jubilant Pharmova Limited pay a dividend?
Yes, it pays an annual dividend of 5.00 INR (0.60% yield).
What asset class is Jubilant Pharmova Limited?
Jubilant Pharmova Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be May 14, 2026. The company currently has a trailing EPS of 27.28.
Company Profile
Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. Its Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom and allergy immunotherapy products. The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. Its Generics segment engages in the development, manufacturing, distribution, sale, and marketing of generic formulations for therapeutic areas comprising cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment offers drug discovery services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment provides patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. The company serves pharmaceutical, biotech, group purchasing organisations, allergists, and hospitals sectors. It sells its products through a network of dealers and distributors. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is based in Noida, India.
Dividend Yield
0.60% (5y avg: 0.70%)
Annual Dividends
5.00 INR
Next ex. div date
July 25, 2025
Payout Ratio
18.26%
Historical Dividends
| Year | Total Dividends |
|---|---|
| 2026 | 5.00 INR |
| Sept. 17, 2026 (estimated) | 5.0000 |
| 2025 | 5.00 INR |
| Sept. 28, 2025 | 5.0000 |
| 2024 | 5.00 INR |
| Sept. 29, 2024 | 5.0000 |
| 2023 | 5.00 INR |
| Sept. 30, 2023 | 5.0000 |
| 2022 | 5.00 INR |
| Oct. 25, 2022 | 5.0000 |
| 2021 | 5.00 INR |
| Oct. 20, 2021 | 5.0000 |
| 2020 | 5.00 INR |
| March 27, 2020 | 5.0000 |
| 2019 | 4.50 INR |
| Oct. 24, 2019 | 4.5000 |
| 2018 | 3.00 INR |
| Oct. 25, 2018 | 3.0000 |
| 2017 | 3.00 INR |
| Sept. 27, 2017 | 3.0000 |
| 2016 | 3.00 INR |
| Aug. 18, 2016 | 3.0000 |
| 2015 | 3.00 INR |
| Aug. 20, 2015 | 3.0000 |
| 2014 | 3.00 INR |
| Aug. 21, 2014 | 3.0000 |
| 2013 | 3.00 INR |
| Aug. 14, 2013 | 3.0000 |
| 2012 | 3.00 INR |
| Aug. 14, 2012 | 3.0000 |
| 2011 | 2.00 INR |
| Aug. 10, 2011 | 2.0000 |
| 2010 | 1.90 INR |
| Sept. 17, 2010 | 1.9048 |
| 2009 | 1.43 INR |
| June 29, 2009 | 1.4286 |
| 2008 | 1.43 INR |
| Sept. 17, 2008 | 1.4286 |
| 2007 | 1.19 INR |
| Sept. 17, 2007 | 1.1905 |
| 2006 | 1.25 INR |
| Sept. 8, 2006 | 1.2500 |
| 2005 | 6.25 INR |
| Aug. 22, 2005 | 6.2500 |
| 2004 | 5.00 INR |
| Sept. 6, 2004 | 1.2500 |
| Jan. 23, 2004 | 3.7500 |
| 2003 | 4.50 INR |
| Sept. 18, 2003 | 4.5000 |
Yearly aggregated dividends
Dividends
|
Jubilant Pharmova Limited
Sep 28, 2025 Paid
Dividend
5.0 INR |
Historical Split Corporate Actions
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion